- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Ovarian Reserve in United Kingdom
Total 2473 results
-
PfizerCompletedBreast Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | NSCLC | Prostate Cancer | Advanced Solid Tumors | Solid TumorsUnited States, Australia
-
Namida LabArkansas Urology; CARTIEnrolling by invitationMelanoma | Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Institutes of Health (NIH)CompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
Massachusetts General HospitalCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States
-
Western Regional Medical CenterTerminatedSarcoma | Breast Cancer | Small Cell Lung Cancer | Pancreatic Cancer | Advanced Cancer | OvarianUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingStage IV Prostate Cancer AJCC v8 | Hepatobiliary Neoplasm | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Stage III Uterine Corpus Cancer AJCC v8 | Stage IV Uterine Corpus Cancer AJCC v8 | Stage IVA Uterine Corpus Cancer AJCC v8 | Stage IVB Uterine Corpus Cancer AJCC v8 | Malignant Neoplasm and other conditionsUnited States
-
AstraZenecaRecruitingBreast Cancer | Ovarian Cancer | Endometrial Cancer | Biliary Tract CarcinomaUnited States, Australia, Spain, United Kingdom, Korea, Republic of, Canada, Italy, Poland, Belgium, China, Japan, Taiwan, Thailand, Hungary, Netherlands
-
Blueprint Medicines CorporationRecruitingGastric Cancer | Ovarian Cancer | Carcinosarcoma | Advanced Solid Tumors | Endometrial Cancer | Esophageal Adenocarcinoma | HER2-negative Breast Cancer | CCNE1 Amplification | HR+ Breast CancerUnited States, Italy, United Kingdom
-
National Cancer Institute (NCI)RecruitingLymphoma | Breast Cancer | Ovarian Cancer | Lung Cancer | Prostate CancerUnited States
-
Ludwig Institute for Cancer ResearchNational Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalTerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma | Mixed Tumor, MesodermalUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedCervical Cancer | Breast Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Bladder Cancer | Vaginal CancerUnited States
-
National Cancer Institute (NCI)CompletedUnresectable Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Recurrent Breast Carcinoma | Metastatic Triple-Negative Breast Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian Carcinoma | Recurrent... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingHairy Cell Leukemia | Recurrent Hairy Cell Leukemia | Hairy Cell Leukemia Variant | Recurrent Hairy Cell Leukemia VariantUnited States
-
Advenchen Laboratories, LLCActive, not recruitingFallopian Tube Carcinoma | Cervical Carcinoma | Endometrial Carcinoma | Ovarian Carcinoma | Primary Peritoneal CarcinomaKorea, Republic of, Spain, United States, United Kingdom, China, Italy
-
Ludwig Institute for Cancer ResearchRoswell Park Cancer InstituteCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMelanoma | Small Cell Lung Cancer | Colorectal Neoplasms | Ovarian Neoplasms | LiposarcomaUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Fallopian Tube Carcinoma | Primary Peritoneal CarcinomaUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Library of Medicine (NLM); U.S. National Science FoundationRecruitingCervical Cancer | Colorectal Cancer | Ovarian Cancer | Bladder Cancer | Uterine CancerUnited States
-
Medstar Health Research InstitutePaxmanCompletedBreast Cancer | Ovarian Cancer | Endometrial Cancer | Gynecologic NeoplasmUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)TerminatedCervical Carcinoma | Vaginal Carcinoma | Ovarian Carcinoma | Uterine Corpus Cancer | Vulvar CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedLymphoma | Carcinoma, Renal Cell | Cancer | Breast Cancer | Ovarian CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAtypical Endometrial Hyperplasia | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | FIGO Grade 2 Endometrial Endometrioid AdenocarcinomaUnited States
-
Ohio State University Comprehensive Cancer CenterAmerican Cancer Society, Inc.; Lance Armstrong FoundationCompletedDepression | Pain | Leukemia | Fatigue | Multiple Myeloma | Insomnia | Pancreatic Cancer | Esophageal Cancer | Lung Cancer | Glioblastoma Multiforme | Sleep Disorders | Uncertainty | Ovarian Neoplasm | Anxiety Disorder | Psychological Intervention | Relapsed Lymphoma | Worry | Cognitive-behavioral Therapy | Stage III or IV Cervical... and other conditionsUnited States
-
Excel Diagnostics and Nuclear Oncology CenterWithdrawnNeuroendocrine Tumors | Pheochromocytoma | Paraganglioma | Unknown Primary Tumors | Pulmonary Neuroendocrine Neoplasm | Thymus Carcinoid | Neuroendocrine Skin Carcinoma | Neuroendocrine Breast Tumor | Neuroendocrine Carcinoma Metastatic | Neuroendocrine Neoplasm of OvaryUnited States
-
Eli Lilly and CompanyLoxo Oncology, Inc.RecruitingUterine Cervical Neoplasms | Carcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Ovarian Neoplasms | Endometrial Neoplasms | Triple Negative Breast Neoplasms | Pancreatic NeoplasmUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Endometrial Adenocarcinoma | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingLymphoma, Non-Hodgkin | Uterine Cervical Neoplasms | Leukemia | Breast Neoplasms | Prostatic Neoplasms | Ovarian Neoplasms | Colonic NeoplasmsUnited States
-
Berg, LLCCompletedCervical Cancer | Cancer | Breast Cancer | Ovarian Cancer | Solid Tumor | Endometrial Cancer | Bone Sarcoma | Primary Peritoneal CarcinomaUnited States
-
TORL Biotherapeutics, LLCTranslational Research in OncologyRecruitingOvarian Cancer | NSCLC | Advanced Solid Tumor | Endometrial CancerUnited States
-
SCRI Development Innovations, LLCNovartis PharmaceuticalsTerminatedSmall Cell Lung Cancer | Ovarian CancerUnited States
-
Abramson Cancer Center at Penn MedicineCompletedBreast Cancer | Colorectal Cancer | Ovarian CancerUnited States
-
Icahn School of Medicine at Mount SinaiNot yet recruitingOvarian Cancer | Malignant Neoplasm of UterusUnited States
-
University of PennsylvaniaNational Cancer Institute (NCI); Alliance for Cancer Gene Therapy; OvaCure Fundation and other collaboratorsTerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaUnited States
-
National Cancer Institute (NCI)TerminatedMelanoma | Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Gastrointestinal CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedTesticular Germ Cell Tumor | Ovarian CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedSarcoma | Small Intestine Cancer | Ovarian CancerUnited States
-
OncXerna Theraputics, Inc.RecruitingA Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid TumorsGastric Cancer | Colorectal Cancer | Ovarian Cancer | Triple Negative Breast CancerUnited States
-
AstraZenecaActive, not recruitingCervical Cancer | Ovarian Cancer | Pharmacokinetics | Endometrial Cancer | Pharmacodynamics | Safety and Tolerability | Advanced Solid Malignancy | Tumour Response | Advanced or Metastatic Breast Cancer | PIK3CA | AKT1 | PTEN | ER Positive | HER2 PositiveUnited States, Italy, Canada, France, Japan, United Kingdom, Spain, Netherlands, Denmark, Singapore
-
Ludwig Institute for Cancer ResearchRoswell Park Cancer Institute; New York University Cancer InstituteCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerUnited States
-
National Cancer Institute (NCI)Enrolling by invitationBreast Cancer | Ovarian Cancer | Uterine CancerUnited States
-
National Cancer Institute (NCI)CompletedBreast Cancer | Ovarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Primary Peritoneal CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's Hospital; National Comprehensive...CompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
University of MinnesotaTerminatedConstipation | Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer | Bowel ObstructionUnited States
-
Genentech, Inc.CompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
Fate TherapeuticsTerminatedBreast Cancer | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | GastroEsophageal CancerUnited States
-
SCRI Development Innovations, LLCGlaxoSmithKlineTerminatedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CarcinomaUnited States
-
Five Prime Therapeutics, Inc.CompletedBreast Cancer | Ovarian Cancer | Advanced Solid Tumors | Endometrial CancerUnited States, Korea, Republic of
-
Washington University School of MedicineVarian Medical SystemsRecruitingHead and Neck Cancer | Gastric Cancer | Ovarian Cancer | Lung Cancer | Brain Cancer | Colon CancerUnited States